What is the recommended treatment for a urinary tract infection (UTI) caused by Enterococcus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enterococcus Urinary Tract Infections

For urinary tract infections caused by Enterococcus species, nitrofurantoin (100mg twice daily for 5 days) or fosfomycin (3g single dose) are the recommended first-line treatments for uncomplicated lower UTIs. 1

Treatment Algorithm Based on Infection Type

Uncomplicated Lower UTI (Cystitis)

  • First-line options:
    • Nitrofurantoin 100mg twice daily for 5 days 1
    • Fosfomycin 3g single oral dose 1
    • Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days (if susceptible) 1

Complicated UTI or Pyelonephritis

  • Treatment duration: 7-14 days 1
  • For susceptible strains:
    • Ampicillin (preferred for ampicillin-susceptible strains) 1, 2
    • Amoxicillin (alternative to ampicillin) 2

Vancomycin-Resistant Enterococcus (VRE) UTIs

  • For lower tract VRE UTIs:

    • Nitrofurantoin, fosfomycin, or doxycycline (if susceptible) 2
  • For upper tract or bacteremic VRE UTIs:

    • Linezolid (indicated for VRE faecium infections, including cases with bacteremia) 3, 2
    • Daptomycin (for ampicillin-resistant strains) 2

Antibiotic Selection Considerations

Susceptibility Patterns

  • Enterococci have intrinsic resistance to cephalosporins, making these ineffective 1
  • E. faecalis is generally more susceptible to antibiotics than E. faecium 1
  • High rates of fluoroquinolone resistance have been observed in E. faecalis strains 1
  • Emerging resistance to nitrofurantoin has been observed, with rates increasing from near zero to 40% in some studies 4

Special Considerations

  • Aminopenicillins may be effective for lower UTIs even when in vitro testing shows resistance, due to high urinary concentrations 5
  • For multidrug-resistant strains, fosfomycin has demonstrated high activity against common UTI pathogens including Enterococcus faecalis 6
  • Linezolid should be reserved for confirmed upper tract or bacteremic VRE UTIs 2

Treatment Duration

  • Uncomplicated lower UTIs: 5-7 days 1
  • Complicated infections or pyelonephritis: 7-14 days 1

Follow-up Recommendations

  • Obtain follow-up culture 1-2 weeks after completing therapy if symptoms persist 1
  • If bacteriuria recurs after treatment, select an alternative agent rather than repeating the same antibiotic 1
  • Infectious disease consultation is highly recommended for managing infections caused by multidrug-resistant organisms 1

Common Pitfalls to Avoid

  1. Treating asymptomatic bacteriuria: Unnecessary use of antibiotics in patients simply colonized with VRE in the urine has become a significant problem in hospitals and long-term care facilities 2

  2. Using cephalosporins: Enterococci have intrinsic resistance to cephalosporins, making these ineffective regardless of susceptibility testing results 1

  3. Overuse of broad-spectrum agents: Reserve linezolid and daptomycin for confirmed upper tract or bacteremic VRE UTIs to prevent development of resistance 2

  4. Inadequate treatment duration: Ensure at least 5-7 days of therapy for uncomplicated UTIs and 7-14 days for complicated infections to ensure complete bacterial eradication 1

  5. Failure to remove indwelling catheters: Consider removal of indwelling urinary catheters when possible, as this can be a source of persistent infection 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.